Hepatocellular carcinoma (HCC) is the third leading cause of cancer
death, and its incidence is increasingworldwide in an alarmingmanner
[1]. Current therapies for this malignancy include antiviral strategies, radiotherapy,
transarterial chemoembolization and surgery,which generally
do not achieve expected results [2]. Thus, novel therapeutic
strategies are urgently needed.